Elanco Animal Health (ELAN) is positioned to potentially beat earnings estimates in its upcoming November 6, 2026 report. The company has a strong track record of beating estimates with an average surprise of 21.79% over the past two quarters. With a positive Earnings ESP of +3.70% and a Zacks Rank #2 (Buy), analysts predict a 70% probability of another earnings beat.
ELAN
Elanco Animal Health Incorporated · NYSE
News
1 latestHeadlines link to the publisher. Not investment advice.